CAPR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Capricor Therapeutics Inc

Watchlist Manager

Watchlist

Price: 28.8001 USD -3.39%

Market Cap: $1.7B

	Capricor Therapeutics Inc NASDAQ:CAPR	US
	Hasbro Inc NASDAQ:HAS	US
P	Polytec Holding AG VSE:PYT	AT
	Lennar Corp NYSE:LEN	US
S	STORE Capital Corp LSE:0LA6	US
D	Dominion Energy Inc F:DOD	US
	NTT Data Corp TSE:9613	JP
	Brookfield Wealth Solutions Ltd TSX:BNT	BM
	Melrose Industries PLC LSE:MRO	UK
	Meta Platforms Inc NASDAQ:META	US
S	Southwest Airlines Co XMUN:SWN	US
	Avery Dennison Corp NYSE:AVY	US
	Eagle Materials Inc NYSE:EXP	US
S	Stora Enso Oyj XBER:ENUR	FI
	Cineverse Corp NASDAQ:CNVS	US
L	LSI Industries Inc F:LS2	US
	Vivoryon Therapeutics NV AEX:VVY	DE
	Citigroup Inc NYSE:C	US
	Federal Realty Investment Trust NYSE:FRT	US
	CoStar Group Inc NASDAQ:CSGP	US
C	CoreWeave Inc NASDAQ:CRWV	US

Profitability Summary

Capricor Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Low Operating Margin

Negative 3Y Average Operating Margin

-267%

Low Net Margin

Negative 3Y Average Net Margin

-270%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-241%

Negative ROE

-47%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-990%

ROIC is Increasing

-1.047% > -461%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.